docetaxelrezvilutamideECOG Performance StatusomHSPColigometastatic hormone-sensitive prostate cancer (omHSPC)First Affiliated Hospital of Wenzhou Medical UniversityADTandrogen deprivation therapyneoadjuvant therapy
…nical value of rezvilutamide combined with ADT, with or without docetaxel, as neoadjuvant treatment for newly diagnosed omHSPC.Trial regi…